MPE has developed a series of Q&As for patients and patient advocates, covering the main issues regarding treatment updates and advocacy relevant topics. Check the following factsheets on:
- Chimeric Antigen Receptor T cell (CAR-T) therapy
- EU funded projects
- SARS-CoV-2 (COVID-19) Vaccination and Treatment
- Chimeric Antigen Receptor T cell (CAR-T) therapy
- SARS-CoV-2 (COVID-19) Vaccination for Myeloma Patients
- COVID-19 (coronavirus) and myeloma and AL amyloidosis treatment
- Health technology assessment (HTA)
- H2020 MMPredict